Project Profile

An Open-label, Randomized Phase IIb/III Active Control Study of Second-line HyperAcute?-Lung (tergenpumatucel-L) Immunotherapy versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer

Keyword Search